HomeTagsNovartis Invests $2.1bn for Nuclear Medicine

Tag: Novartis Invests $2.1bn for Nuclear Medicine

Novartis Invests $2.1bn for Nuclear Medicine

Novartis Invests $2.1bn for Nuclear Medicine Novartis is paying $2.1 billion for nuclear medicine specialist Endocyte in Chief Executive Vas Narasimhan’s latest deal to reshape the Swiss drugs group from a pill maker to a producer of sophisticated therapies. Narasimhan, who raised Novartis’s 2018 revenue forecast...